13
May
2025
Biologic Drug Discovery Made Faster: Peyton Greenside on The Long Run
Peyton Greenside is today’s guest on The Long Run. Peyton is the co-founder and CEO of San Mateo, Calif.-based BigHat Biosciences. The company was started in 2019 to build on advances in synthetic biology and machine learning to design antibody drugs with a variety of different properties, faster. The company has gone on to raise more than $100 million in... Read More